Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer

Gastric cancer (GC) is the fifth most common cancer worldwide. Despite recent improvements in treatment quality and options, advanced gastric cancer remains one of the hardest to cure cancers, with a median overall survival (OS) of 10–12 months and a 5-year OS of approximately 5–20%. There is an unm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahraman, Seda, Yalcin, Suayib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286155/
https://www.ncbi.nlm.nih.gov/pubmed/34285507
http://dx.doi.org/10.2147/OTT.S315252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286155/
https://www.ncbi.nlm.nih.gov/pubmed/34285507
http://dx.doi.org/10.2147/OTT.S315252

Ejemplares similares